Montecalvo Antonio S.
SEC CIK 1759261 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ORGO | Organogenesis Holdings Inc. | VP, Health Policy | 226.2K | — | $902.7K | 18 | 2022-02-15 | 2026-02-18 |
Most active insiders at ORGO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | NUSSDORF GLENN H | Dir, 10% | — | $2.62M |
| 2 | Driscoll Michael Joseph | Dir | $26.7K | — |
| 3 | Leibowitz Arthur S | Dir | $13.4K | — |
| 4 | Lustig Garrett | Dir | — | — |
| 5 | Cavorsi Robert | VP, Strategy | — | — |
| 6 | Quintero Gilberto | Dir | — | — |
| 7 | Francisco David | CFO | — | — |
| 8 | Duraibabu Prathyusha | Dir | — | — |
| 9 | Korfin Michele Ilene | Dir | — | — |
| 10 | Montecalvo Antonio S. | VP, Health Policy | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-03-03 | 2026-02-18 | ORGO | Organogenesis Holdings Inc. | Montecalvo Antonio S. | VP, Health Policy | F - Tax | $3.84 | -3,778 | 226.2K | -2% | -$14.5K |
| A | 2026-03-03 | 2026-02-18 | ORGO | Organogenesis Holdings Inc. | Montecalvo Antonio S. | VP, Health Policy | A - Grant | $0.00 | +11.3K | 230.0K | +5% | $0 |
| DM | 2026-02-20 | 2026-02-18 | ORGO | Organogenesis Holdings Inc. | Montecalvo Antonio S. | VP, Health Policy | A - Grant | $0.00 | +51.8K | 229.9K | +29% | $0 |
| D | 2026-02-20 | 2026-02-18 | ORGO | Organogenesis Holdings Inc. | Montecalvo Antonio S. | VP, Health Policy | F - Tax | $3.84 | -3,741 | 226.2K | -2% | -$14.4K |
| M | 2026-02-18 | 2026-02-15 | ORGO | Organogenesis Holdings Inc. | Montecalvo Antonio S. | VP, Health Policy | F - Tax | $3.73 | -18.6K | 195.3K | -9% | -$69.4K |
| D | 2025-02-21 | 2025-02-19 | ORGO | Organogenesis Holdings Inc. | Montecalvo Antonio S. | VP, Health Policy | A - Grant | $0.00 | +42.5K | 196.7K | +28% | $0 |
| M | 2025-02-19 | 2025-02-15+ | ORGO | Organogenesis Holdings Inc. | Montecalvo Antonio S. | VP, Health Policy | F - Tax | $3.70 | -14.1K | 154.2K | -8% | -$52.1K |
| 2024-04-03 | 2024-04-01 | ORGO | Organogenesis Holdings Inc. | Montecalvo Antonio S. | VP, Health Policy | F - Tax | $2.80 | -1,752 | 168.3K | -1% | -$4,906 | |
| D | 2024-02-23 | 2024-02-21 | ORGO | Organogenesis Holdings Inc. | Montecalvo Antonio S. | VP, Health Policy | A - Grant | $0.00 | +43.7K | 170.0K | +35% | $0 |
| M | 2024-02-20 | 2024-02-15+ | ORGO | Organogenesis Holdings Inc. | Montecalvo Antonio S. | VP, Health Policy | F - Tax | $3.67 | -10.6K | 127.0K | -8% | -$39.0K |
| 2023-04-04 | 2023-04-01 | ORGO | Organogenesis Holdings Inc. | Montecalvo Antonio S. | VP, Health Policy | F - Tax | $2.13 | -2,097 | 136.9K | -2% | -$4,467 | |
| D | 2023-02-24 | 2023-02-22 | ORGO | Organogenesis Holdings Inc. | Montecalvo Antonio S. | VP, Health Policy | A - Grant | $0.00 | +99.4K | 139.0K | +251% | $0 |
| M | 2023-02-17 | 2023-02-15+ | ORGO | Organogenesis Holdings Inc. | Montecalvo Antonio S. | VP Health Policy, Contracting | F - Tax | $2.86 | -1,966 | 39.6K | -5% | -$5,619 |
| 2022-04-05 | 2022-04-01 | ORGO | Organogenesis Holdings Inc. | Montecalvo Antonio S. | VP, Health Policy | F - Tax | $7.89 | -2,738 | 41.6K | -6% | -$21.6K | |
| DM | 2022-03-11 | 2022-03-10 | ORGO | Organogenesis Holdings Inc. | Montecalvo Antonio S. | VP, Health Policy | M - OptEx | $3.46 | +68.5K | 141.7K | +94% | +$237.0K |
| DM | 2022-03-11 | 2022-03-09+ | ORGO | Organogenesis Holdings Inc. | Montecalvo Antonio S. | VP, Health Policy | S - Sale+OE | $8.40 | -107.4K | 73.2K | -59% | -$902.7K |
| D | 2022-02-17 | 2022-02-16 | ORGO | Organogenesis Holdings Inc. | Montecalvo Antonio S. | VP Health Policy, Contracting | F - Tax | $7.78 | -718 | 83.2K | -0.9% | -$5,586 |
| D | 2022-02-17 | 2022-02-15 | ORGO | Organogenesis Holdings Inc. | Montecalvo Antonio S. | VP Health Policy, Contracting | A - Grant | $0.00 | +14.4K | 83.9K | +21% | $0 |
Purchase Sale Sale after option exercise All abbreviations